Concepedia

Publication | Open Access

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study

DOIFull Paper Access

182

Citations

9

References

2017

Year

Stanley Cohen, Mark C. Genovese, Ernest Choy, Fernando Pérez-Ruiz, Alan K. Matsumoto, Karel Pavelká, José L. Pablos, Warren Rizzo, Paweł Hrycaj, Nan Zhang,
Annals of the Rheumatic Diseases

Abstract

NCT01970475; Results.

References

YearCitations

Page 1